
Nova Eye Medical Limited (ELXMF) Shareholder/Analyst Call Transcript
Nova Eye Medical Limited (ELXMF) Shareholder/Analyst Call Transcript
Loading news...

Nova Eye Medical Limited (ELXMF) Shareholder/Analyst Call Transcript

Nova Eye Medical Limited (ELXMF) Q2 2026 Earnings Call Transcript

Nova Eye Medical Limited (ELXMF) Q2 2026 Sales/Trading Call Transcript

Nova Eye Medical Limited (OTCPK:ELXMF) Discusses Clinical Insights and Practice Advantages of iTrack Advance Glaucoma Device November 25, 2025 5:30 PM EST Company Participants Mark Flynn - Investor Relations Thomas Spurling - MD & Executive Director Conference Call Participants Dr. Mahmoud Khaimi Presentation Mark Flynn Investor Relations Good morning, everyone, and thank you for joining us at Nova Eye. We're here to walk you through the clinical use of the iTrack Advance and share some direct insights from the field.